ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Stryker recalls two metal-on-metal hip products for fear of corrosion

July 6, 2012 5:41 pm by | 0 Comments

stopIn another hit to the safety of metal-on-metal hip replacements, Stryker announced Friday that it is voluntarily recalling two metal-on-metal hip products prompted by fears of corrosion.

The company said that the Rejuvenate and ABG II modular neck him stems are being recalled given the “potential risks associated with fretting and corrosion at the modular neck junction.”

In late June, the Food and Drug Administration conducted hearings to determine the safety of metal-on-metal hip replacements. The scrutiny comes from mounting evidence that these products appear to fail early, often cause swelling and pain, among other complications. Sometimes surgeons have to perform a revision surgery. The webcasts of the two days of FDA hearings can be seen here and here.

In a website meant to communicate with patients who either have a Stryker hip or one of the two recalled products, Stryker says the incidence of complications arising out of these products is “extremely low.” Still it advised patients who have these implants to contact their surgeon.

Advertisement

In the FDA database that tracks adverse events, there are multiple reports associated with the Rejuvenate neck stemthat show that many patients suffered pain, swelling and required revision surgery.

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.

Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.


Related Topics:

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Next Story
Drug reformulation company raising $2 million to advance cancer treatment
Close